The expression of MAD2L1 was analyzed using the ONCOMINE database and the CCLE database and was proved to be upregulated in HCC tissues and cells compared with the control tissues and cells (all P < 0.05, Figures 6(a)–6(f)). This evidence concerns the gene MAD2L1 and hepatocellular carcinoma.